CO2018011408A2 - Compuestos de pirimidina como inhibidores de la quinasa jak - Google Patents

Compuestos de pirimidina como inhibidores de la quinasa jak

Info

Publication number
CO2018011408A2
CO2018011408A2 CONC2018/0011408A CO2018011408A CO2018011408A2 CO 2018011408 A2 CO2018011408 A2 CO 2018011408A2 CO 2018011408 A CO2018011408 A CO 2018011408A CO 2018011408 A2 CO2018011408 A2 CO 2018011408A2
Authority
CO
Colombia
Prior art keywords
compounds
inhibitors
pyrimidine compounds
jak kinase
provides
Prior art date
Application number
CONC2018/0011408A
Other languages
English (en)
Inventor
Anne-Marie Beausoleil
Ryan Hudson
Jennifer Kozak
Melissa Fleury
Paul R Fatheree
Dante D Podesto
Xiaojun Huang
Original Assignee
Theravance Biopharma R&D Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Biopharma R&D Ip Llc filed Critical Theravance Biopharma R&D Ip Llc
Publication of CO2018011408A2 publication Critical patent/CO2018011408A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

La invención provee compuestos de fórmula (I): (I) donde las variables se definen en la memoria descriptiva, o una sal farmacéuticamente aceptable de los mismos, que son inhibidores de las quinasas JAK. La invención también provee composiciones farmacéuticas que comprenden tales compuestos, métodos de uso de tales compuestos para tratar enfermedades gastrointestinales y otras enfermedades inflamatorias, y procesos e intermediarios útiles para preparar tales compuestos.
CONC2018/0011408A 2016-04-28 2018-10-25 Compuestos de pirimidina como inhibidores de la quinasa jak CO2018011408A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662328737P 2016-04-28 2016-04-28
PCT/US2017/029796 WO2017189822A1 (en) 2016-04-28 2017-04-27 Pyrimidine compounds as jak kinase inhibitors

Publications (1)

Publication Number Publication Date
CO2018011408A2 true CO2018011408A2 (es) 2018-11-13

Family

ID=58672793

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0011408A CO2018011408A2 (es) 2016-04-28 2018-10-25 Compuestos de pirimidina como inhibidores de la quinasa jak

Country Status (20)

Country Link
US (3) US10028960B2 (es)
EP (1) EP3433253B1 (es)
JP (1) JP6881879B2 (es)
KR (1) KR102244257B1 (es)
CN (1) CN109071529B (es)
AU (1) AU2017258186B2 (es)
BR (1) BR112018072168A2 (es)
CA (1) CA3020506A1 (es)
CL (1) CL2018003060A1 (es)
CO (1) CO2018011408A2 (es)
DK (1) DK3433253T3 (es)
EA (1) EA035226B1 (es)
ES (1) ES2779880T3 (es)
IL (1) IL262386B (es)
MX (1) MX2018013191A (es)
PT (1) PT3433253T (es)
SG (1) SG11201809342YA (es)
TW (1) TWI726094B (es)
WO (1) WO2017189822A1 (es)
ZA (1) ZA201807179B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6692836B2 (ja) 2015-05-28 2020-05-13 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー Ｊａｋキナーゼ阻害剤としてのナフチリジン化合物
PL3712152T3 (pl) 2015-11-03 2021-08-02 Topivert Pharma Limited Pochodne 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pirydyny i 1,4,5,6,7,8-heksahydroimidazo[4,5-d]azepiny jako inhibitory kinaz janusowych
WO2017077288A1 (en) 2015-11-03 2017-05-11 Topivert Pharma Limited 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors
EA035226B1 (ru) * 2016-04-28 2020-05-19 ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи Пиримидиновые соединения в качестве ингибиторов jak киназы
CU24671B1 (es) * 2017-10-27 2023-07-12 Theravance Biopharma R&D Ip Llc Compuesto de pirimidina inhibidor de las janocinasas, composición, forma cristalina y proceso de preparación
EP3810094A1 (en) 2018-06-20 2021-04-28 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a jak or other kinase inhibitor
WO2020108516A1 (zh) * 2018-11-27 2020-06-04 江苏豪森药业集团有限公司 含氮杂芳类衍生物调节剂、其制备方法和应用
EP3889152A4 (en) * 2018-11-30 2022-09-07 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. HETEROAROMATIC DERIVATIVES FOR USE AS REGULATORS, PROCESS FOR THEIR PREPARATION AND THEIR USE
WO2020219640A1 (en) * 2019-04-24 2020-10-29 Theravance Biopharma R&D Ip, Llc Pyrimidine jak inhibitors for the treatment of skin diseases
TW202106682A (zh) 2019-04-24 2021-02-16 美商施萬生物製藥研發Ｉｐ有限責任公司 作為jak激酶抑制劑之酯類及碳酸酯類嘧啶化合物
JP2023528239A (ja) * 2020-05-14 2023-07-04 テラバンス バイオファーマ アールアンドディー アイピー リミテッド ライアビリティ カンパニー 腸管選択的ｊａｋ３阻害剤の投与
WO2022083687A1 (zh) * 2020-10-21 2022-04-28 南京明德新药研发有限公司 硒杂环类化合物及其应用
WO2023011359A1 (zh) * 2021-08-05 2023-02-09 南京明德新药研发有限公司 桥环类化合物及其应用
CN113883920B (zh) * 2021-10-25 2024-01-23 安徽华铂再生资源科技有限公司 一种降低空分装置空冷塔出口温度的方法
WO2023202706A1 (zh) * 2022-04-21 2023-10-26 南京明德新药研发有限公司 硒杂环类化合物的盐型和晶型及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
EP1345922B1 (en) 2000-12-21 2006-05-31 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
EP1841760B1 (en) * 2004-12-30 2011-08-10 Exelixis, Inc. Pyrimidine derivatives as kinase modulators and method of use
EP1951716B1 (en) 2005-11-16 2011-05-04 Vertex Pharmaceuticals, Inc. Aminopyrimidines useful as kinase inhibitors
UY30444A1 (es) 2006-06-30 2008-01-31 Astrazeneca Ab Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
US8222256B2 (en) 2006-07-05 2012-07-17 Exelixis, Inc. Methods of using IGFIR and ABL kinase modulators
US8815877B2 (en) 2011-12-22 2014-08-26 Genentech, Inc. Serine/threonine kinase inhibitors
WO2015094803A1 (en) * 2013-12-16 2015-06-25 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
NO2721710T3 (es) * 2014-08-21 2018-03-31
JP6692836B2 (ja) 2015-05-28 2020-05-13 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー Ｊａｋキナーゼ阻害剤としてのナフチリジン化合物
EA035226B1 (ru) 2016-04-28 2020-05-19 ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи Пиримидиновые соединения в качестве ингибиторов jak киназы

Also Published As

Publication number Publication date
IL262386A (en) 2018-11-29
BR112018072168A2 (pt) 2019-02-12
DK3433253T3 (da) 2020-04-06
US20200046709A1 (en) 2020-02-13
SG11201809342YA (en) 2018-11-29
CA3020506A1 (en) 2017-11-02
EP3433253B1 (en) 2020-02-12
MX2018013191A (es) 2019-02-13
US11110095B2 (en) 2021-09-07
US20180303836A1 (en) 2018-10-25
US20170312280A1 (en) 2017-11-02
CN109071529A (zh) 2018-12-21
EA201892436A1 (ru) 2019-04-30
JP6881879B2 (ja) 2021-06-02
KR102244257B1 (ko) 2021-04-26
IL262386B (en) 2021-08-31
TW201739747A (zh) 2017-11-16
CL2018003060A1 (es) 2018-12-14
JP2019514903A (ja) 2019-06-06
PT3433253T (pt) 2020-04-30
AU2017258186A1 (en) 2018-11-15
AU2017258186B2 (en) 2020-09-17
ZA201807179B (en) 2019-08-28
KR20190002591A (ko) 2019-01-08
US10028960B2 (en) 2018-07-24
WO2017189822A1 (en) 2017-11-02
EA035226B1 (ru) 2020-05-19
ES2779880T3 (es) 2020-08-20
US10485803B2 (en) 2019-11-26
CN109071529B (zh) 2021-08-06
EP3433253A1 (en) 2019-01-30
TWI726094B (zh) 2021-05-01

Similar Documents

Publication Publication Date Title
CO2018011408A2 (es) Compuestos de pirimidina como inhibidores de la quinasa jak
CO2017012267A2 (es) Compuestos de naftiridina como inhibidores de la quinasa jak
CO2018005640A2 (es) Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria
CO2020001469A2 (es) Compuestos bicíclicos de pirazol y triazolo como inhibidores de las cinasas jak
NI201700020A (es) Compuestos de aminopirimidinilo como inhibidores de jak
CL2017000712A1 (es) Pirimidinonas como inhibidores del factor xia
CO2021002977A2 (es) Dimetilaminoazetidinaminas como inhibidores de jak
EA201691302A1 (ru) Новые гетероциклические соединения
CR20150633A (es) Derivados del bipirazol como inhibidores jak
EA201790078A1 (ru) Ингибиторы mnk и связанные с ними способы
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
CL2018001569A1 (es) Compuestos heteroaromáticos como inhibidores de btk
UY34917A (es) Inhibidores de la producción de leucotrieno-a4-hidrolasa (lta4h), composiciones farmacéuticas que los contienen y proceso para su preparación
DOP2020000083A (es) Compuesto de pirimidina como inhibidor de las janocinasas
EA201792689A1 (ru) Производные 2-(пиразолопиридин-3-ил)пиримидина в качестве ингибиторов jak
CO2019001181A2 (es) Compuestos de heteroarilcarboxamida como inhibidores de ripk2
EA201790830A1 (ru) Ингибиторы альдостеронсинтазы
CO2019008110A2 (es) Activador de nrf2
EA201650003A1 (ru) Соединённые циклоалкилом дигетероциклические производные
EA201600002A1 (ru) Производные пролекарства замещенных триазолопиридинов
EA201891319A1 (ru) Соединения алкилдигидрохинолинсульфонамида
EA202192822A1 (ru) Нафтиридиновые соединения в качестве ингибиторов jak киназы
EA201892188A1 (ru) Соединения пирролотриазина в качестве ингибиторов tam